Ligand Pharmaceuticals Inc (LGND)

Free Cash Flow

$131.37M

TTM · Period ending: · USD

LGND logo

LGND Free Cash Flow

Latest reported$131.37M
LGND TTM Free Cash Flow (-$14.90M → $131.37M)
High-resolution chart · PNG

LGND free cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Free Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFree Cash Flow (USD)
131,365,000
122,956,000
48,763,000
30,687,000
39,901,000
35,493,000
79,809,000
58,749,000
43,619,000
32,159,000
45,107,000
89,749,000
97,790,000
103,365,000
118,967,000
93,073,000
96,126,000
106,419,000
66,633,000
37,265,000
29,720,000
37,728,000
47,300,000
41,329,000
24,424,000
-60,225,000
-31,889,000
-312,000
32,967,000
167,669,000
182,172,000
189,861,000
190,408,000
127,038,000
86,414,000
76,244,000
64,952,000
46,386,000
34,679,000
27,275,000
20,097,000
33,972,000
30,864,000
26,747,000
21,056,000
19,436,000
16,067,000
19,415,000
15,383,000
14,665,000
15,753,000
-1,117,000
-1,835,000
-6,054,000
-8,483,000
4,411,000
4,527,000
-2,544,000
-1,250,000
-8,230,000
-14,743,000
-10,299,000
-27,137,000
-28,486,000
-32,365,000
-25,920,000
-34,323,000
-26,897,000
-28,856,000
-35,860,000
-21,120,000
-36,130,000
-36,882,000
-62,327,000
-98,167,000
-173,569,000
-188,239,000
-165,565,000
-140,304,000
-44,240,000
-42,689,000
-44,211,000
-27,231,000
-11,756,000
7,776,000
3,524,000
2,150,000
-17,495,000
-13,046,000
2,908,000
-2,509,000
-19,986,000
-20,814,000
-36,622,000
-28,273,000
-22,344,000
-25,256,000
-9,511,000
-21,880,000
-27,164,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.